Oncogenic β-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer

By sjmartinez • September 19, 2022

Liu F, Gai X, Wu Y, Zhang B, Wu X, Cheng R, Tang B, Shang K, Zhao N, Deng W, Chen J, Zhang Z, Gu S, Zheng L, Zhang H. Oncogenic β-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer. Proc Natl Acad Sci U S A. 2022 Sep 27;119(39):e2202157119. doi: 10.1073/pnas.2202157119. Epub 2022 Sep 19. PMID: 36122209.

Tags: AKT2, CAD, Cardiology/Epi, liver cancer, Publications, pyrimidine synthesis, β-catenin

Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis

Umbleja T, Zafar MU, McCallum S, Gattu AK, Zanni MV, Bloomfield GS, Malvestutto CD, Fichtenbaum CJ, Currier JS, Sponseller CA, Diggs MR, Chu SM, Lu[...]

Trends and Disparities in Aortic Stenosis and Coronary Artery Disease-Related Mortality Among U.S. Adults Aged ≥65 Years, 1999-2024

Daniyal SM, Sarwar M, Fahim SL, Khatoon NM, Noor A, Batool F, Riaz M, Ajaz H, Gondal HT, Aftab Z, Gul I, Fonarow GC. Trends[...]

Comparison of Inpatient End-of-Life Care Intensity Between Heart Failure and Cancer

Halloran S, Meng Z, Harap R, Baldridge A, Wilcox J, Rao A, Adaboh A, Fonarow GC, Allen LA, Tibrewala A, Chuzi S. Comparison of Inpatient[...]